ePrivacy and GPDR Cookie Consent by TermsFeed Generator

OXALIPLATINA MYLAN

5MG/ML INF PLV SOL 2X50MG

SÚKL code 0144409
Name of the product OXALIPLATINA MYLAN
_MA_MEDICATION_DETAIL_INFO_MED_NAME i OXALIPLATINA MYLAN
Supplement 5MG/ML INF PLV SOL 2X50MG
Strenght 5MG/ML
Pharmaceutical form Powder for solution for infusion
Package 2X50MG
Route Intravenous use
Language of the pack Czech/Slovak
Wrap type Vial
Legal status na lékařský předpis
Active substance OXALIPLATIN (OXALIPLATINUM)
ATC group L01XA03
ATC group name OXALIPLATINA

Marketing authorisation information

Registration Number 44/ 646/07-C
Type of MA A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state
MA status B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till)
Placed on the market till 31. 05. 2022
MA Holder Mylan S.A.S., Saint-Priest
MA Holder country FRANCIE
Actual MA holder VIATRIS LIMITED, Dublin
Actual MA holder country IRSKO

Back to list